Major acute cardiovascular events in patients with inflammatory bowel disease

被引:7
|
作者
Gill, Gauravpal S. [1 ]
Fernandez, Stephen J. [2 ]
Malhotra, Nidhi [1 ,3 ]
Mete, Mihriye [2 ]
Garcia-Garcia, Hector M. [1 ]
机构
[1] MedStar Washington Hosp Ctr, Dept Med, Washington, DC USA
[2] MedStar Hlth Res Inst, Dept Biostat & Informat, Hyattsville, MD USA
[3] Georgetown Univ, Dept Med, Washington, DC USA
关键词
cardiovascular events; coronary artery disease; inflammatory bowel disease; outcomes;
D O I
10.1097/MCA.0000000000000899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Systemic inflammation and immune-mediated diseases have been associated with ischemic heart disease in addition to traditional risk factors. In this study, we investigate associations between inflammatory bowel disease (IBD) and acute cardiovascular events. Methods An observational study where patient data were extracted from our health system patient pool of 3 917 894. Propensity scores were calculated for all 15 292 patients (0.39%) with IBD to assemble a 1:1 matched cohort balanced for age, gender, race and known cardiovascular risk factors including hypertension, hyperlipidemia, diabetes mellitus and smoking (current and former). Secondary analyses were performed independently for 6658 patients with ulcerative colitis and 9406 patients with Crohn's disease. ICD-9 and ICD-10 codes were used to identify cardiovascular risk factors and outcomes. Results Matched patients (n = 30 584) had a mean age of 51 years, with 58% being women, and 63% Caucasian. During the median follow-up of 4.4 years, all-cause mortality was observed in 1.7 versus 1.2% of patients from IBD and non-IBD groups, respectively [hazard ratio, 1.31; 95% confidence interval (CI), 1.08-1.58; P = 0.005]. Combined outcome for myocardial infarction or cardiovascular mortality was noted in 2.3 and 2.1% from IBD and non-IBD groups, respectively (hazard ratio, 1.04; 95% CI, 0.90-1.21; P = 0.588), while hazard ratios for cardiovascular mortality, myocardial infarction and unstable angina were 1.04 (0.74-1.47; P = 0.833), 1.05 (0.89-1.23; P = 0.591) and 1.10 (0.83-1.46; P = 0.524), respectively. Conclusions Among patients with IBD, incidence of acute coronary events did not show a statistically significant difference when compared to the matched cohort.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [31] The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease
    Lyu, Linling
    Chen, Dongfeng
    Yu, Minhao
    Yang, Yang
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (11) : 1480 - 1481
  • [32] Are Patients With Inflammatory Bowel Diseases at Increased Risk for Cardiovascular Disease?
    Theocharidou, Eleni
    Gossios, Thomas D.
    Karagiannis, Asterios
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (12) : 2134 - 2135
  • [33] Spotlight on Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease
    Sleutjes, Jasmijn A. M.
    Roeters van Lennep, Jeanine E.
    de Vries, Annemarie C.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (09) : 4326 - 4329
  • [34] Cardiovascular risk profile in Greek patients with inflammatory bowel disease
    Tsoukali, E.
    Mantaka, A.
    Orfanoudaki, E.
    Viazis, N.
    Pitsavos, C.
    Panagiotakos, D.
    Mantzaris, G.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S520 - S520
  • [35] Spotlight on Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease
    Jasmijn A. M. Sleutjes
    Jeanine E. Roeters van Lennep
    Annemarie C. de Vries
    Digestive Diseases and Sciences, 2022, 67 : 4326 - 4329
  • [36] Increased Cardiovascular Risk in Patients With Inflammatory Bowel Disease Reply
    Aniwan, Satimai
    Loftus, Edward V., Jr.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (04) : 800 - 801
  • [37] Thromboembolic events in inflammatory bowel disease
    Skouloudis, E.
    Kourkoulis, P.
    Vrakas, S.
    Michalopoulos, G.
    SCIENTIFIC CHRONICLES, 2021, 26 (03) : 445 - 455
  • [38] REMNANT CHOLESTEROL PREDICTS MAJOR CARDIOVASCULAR EVENTS IN CARDIOVASCULAR DISEASE PATIENTS WITH NAFLD
    Larcher, Barbara
    Mader, Arthur
    Sprenger, Lukas
    Vonbank, Alexander
    Maechler, Maximilian
    Plattner, Thomas
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2068 - 2068
  • [39] Remnant Cholesterol Predicts Major Cardiovascular Events in Cardiovascular Disease Patients with NAFLD
    Larcher, Barbara
    Mader, Arthur
    Sprenger, Lukas
    Vonbank, Alexander
    Maechler, Maximilian
    Plattner, Thomas
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2023, 72
  • [40] Remnant cholesterol predicts major cardiovascular events in cardiovascular disease patients with NAFLD
    Larcher, B.
    Mader, A.
    Sprenger, L.
    Vonbank, A.
    Maechler, M.
    Plattner, T.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    EUROPEAN HEART JOURNAL, 2023, 44